
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Novel mechanisms and clinical trial endpoints in intestinal fibrosis*
Jie Wang, Sinan Lin, J. Mark Brown, et al.
Immunological Reviews (2021) Vol. 302, Iss. 1, pp. 211-227
Open Access | Times Cited: 77
Jie Wang, Sinan Lin, J. Mark Brown, et al.
Immunological Reviews (2021) Vol. 302, Iss. 1, pp. 211-227
Open Access | Times Cited: 77
Showing 1-25 of 77 citing articles:
Revisiting fibrosis in inflammatory bowel disease: the gut thickens
Silvia D’Alessio, Federica Ungaro, Daniele Noviello, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 19, Iss. 3, pp. 169-184
Closed Access | Times Cited: 138
Silvia D’Alessio, Federica Ungaro, Daniele Noviello, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 19, Iss. 3, pp. 169-184
Closed Access | Times Cited: 138
Fibroblast and myofibroblast activation in normal tissue repair and fibrosis
Fereshteh S. Younesi, Andrew Miller, Thomas H. Barker, et al.
Nature Reviews Molecular Cell Biology (2024) Vol. 25, Iss. 8, pp. 617-638
Closed Access | Times Cited: 138
Fereshteh S. Younesi, Andrew Miller, Thomas H. Barker, et al.
Nature Reviews Molecular Cell Biology (2024) Vol. 25, Iss. 8, pp. 617-638
Closed Access | Times Cited: 138
Fibrosis: Types, Effects, Markers, Mechanisms for Disease Progression, and Its Relation with Oxidative Stress, Immunity, and Inflammation
Samar A. Antar, Nada A. Ashour, Mohamed E. Marawan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4004-4004
Open Access | Times Cited: 133
Samar A. Antar, Nada A. Ashour, Mohamed E. Marawan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4004-4004
Open Access | Times Cited: 133
The Role of Myofibroblasts in Physiological and Pathological Tissue Repair
Ronen Schuster, Fereshteh S. Younesi, Maya Ezzo, et al.
Cold Spring Harbor Perspectives in Biology (2022) Vol. 15, Iss. 1, pp. a041231-a041231
Open Access | Times Cited: 106
Ronen Schuster, Fereshteh S. Younesi, Maya Ezzo, et al.
Cold Spring Harbor Perspectives in Biology (2022) Vol. 15, Iss. 1, pp. a041231-a041231
Open Access | Times Cited: 106
Orally administration of cerium oxide nanozyme for computed tomography imaging and anti-inflammatory/anti-fibrotic therapy of inflammatory bowel disease
Yameng Cao, Kai Cheng, Mei Yang, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 65
Yameng Cao, Kai Cheng, Mei Yang, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 65
Is the Macrophage Phenotype Determinant for Fibrosis Development?
L Lis-López, C Bauset, Marta Seco-Cervera, et al.
Biomedicines (2021) Vol. 9, Iss. 12, pp. 1747-1747
Open Access | Times Cited: 68
L Lis-López, C Bauset, Marta Seco-Cervera, et al.
Biomedicines (2021) Vol. 9, Iss. 12, pp. 1747-1747
Open Access | Times Cited: 68
The role of Nrf2 in the pathogenesis and treatment of ulcerative colitis
Shuai Peng, Lei Shen, Xiaoyun Yu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 35
Shuai Peng, Lei Shen, Xiaoyun Yu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 35
Chaperone‐mediated autophagy: Molecular mechanisms, biological functions, and diseases
Ruchen Yao, Jun Shen
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 25
Ruchen Yao, Jun Shen
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 25
Recent advances in intestinal fibrosis
Marco Vincenzo Lenti, Giovanni Santacroce, Giacomo Broglio, et al.
Molecular Aspects of Medicine (2024) Vol. 96, pp. 101251-101251
Closed Access | Times Cited: 8
Marco Vincenzo Lenti, Giovanni Santacroce, Giacomo Broglio, et al.
Molecular Aspects of Medicine (2024) Vol. 96, pp. 101251-101251
Closed Access | Times Cited: 8
Fibrosis: cross-organ biology and pathways to development of innovative drugs
Florian Rieder, Laura E. Nagy, Toby M. Maher, et al.
Nature Reviews Drug Discovery (2025)
Closed Access | Times Cited: 1
Florian Rieder, Laura E. Nagy, Toby M. Maher, et al.
Nature Reviews Drug Discovery (2025)
Closed Access | Times Cited: 1
Development of antifibrotic therapy for stricturing Crohn’s disease: lessons from randomized trials in other fibrotic diseases
Sinan Lin, Ren Mao, Chenchen Qian, et al.
Physiological Reviews (2021) Vol. 102, Iss. 2, pp. 605-652
Open Access | Times Cited: 51
Sinan Lin, Ren Mao, Chenchen Qian, et al.
Physiological Reviews (2021) Vol. 102, Iss. 2, pp. 605-652
Open Access | Times Cited: 51
Fibro-Stenosing Crohn’s Disease: What Is New and What Is Next?
Virginia Solitano, Arianna Dal Buono, Roberto Gabbiadini, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 9, pp. 3052-3052
Open Access | Times Cited: 21
Virginia Solitano, Arianna Dal Buono, Roberto Gabbiadini, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 9, pp. 3052-3052
Open Access | Times Cited: 21
Cellular and Molecular Mechanisms of Intestinal Fibrosis
Xiaomin Wu, Xiaoxuan Lin, Jinyu Tan, et al.
Gut and Liver (2023) Vol. 17, Iss. 3, pp. 360-374
Open Access | Times Cited: 20
Xiaomin Wu, Xiaoxuan Lin, Jinyu Tan, et al.
Gut and Liver (2023) Vol. 17, Iss. 3, pp. 360-374
Open Access | Times Cited: 20
Intestinal strictures in Crohn’s disease: a 2021 update
Xiaoxuan Lin, Yu Wang, Zishan Liu, et al.
Therapeutic Advances in Gastroenterology (2022) Vol. 15
Open Access | Times Cited: 24
Xiaoxuan Lin, Yu Wang, Zishan Liu, et al.
Therapeutic Advances in Gastroenterology (2022) Vol. 15
Open Access | Times Cited: 24
“Two-birds-one-stone” colon-targeted nanomedicine treats ulcerative colitis via remodeling immune microenvironment and anti-fibrosis
Jiaxin Zhang, Ante Ou, Xueping Tang, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 23
Jiaxin Zhang, Ante Ou, Xueping Tang, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 23
Single-cell Expression Atlas Reveals Cell Heterogeneity in the Creeping Fat of Crohn’s Disease
Weigang Shu, Yongheng Wang, Chuanding Li, et al.
Inflammatory Bowel Diseases (2023) Vol. 29, Iss. 6, pp. 850-865
Closed Access | Times Cited: 15
Weigang Shu, Yongheng Wang, Chuanding Li, et al.
Inflammatory Bowel Diseases (2023) Vol. 29, Iss. 6, pp. 850-865
Closed Access | Times Cited: 15
PPAR-Gamma Orchestrates EMT, AGE, and Cellular Senescence Pathways in Colonic Epithelium and Restrains the Progression of IBDs
Simona Pompili, Antonella Vetuschi, Giovanni Latella, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8952-8952
Open Access | Times Cited: 14
Simona Pompili, Antonella Vetuschi, Giovanni Latella, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8952-8952
Open Access | Times Cited: 14
LncRNA MSC-AS1 regulates SNIP1 SUMOylation-mediated EMT by binding to SENP1 to promote intestinal fibrosis in Crohn's disease
Wei Chen, Zeyan Xu, Jingjing Jiang, et al.
International Journal of Biological Macromolecules (2024) Vol. 262, pp. 129921-129921
Closed Access | Times Cited: 5
Wei Chen, Zeyan Xu, Jingjing Jiang, et al.
International Journal of Biological Macromolecules (2024) Vol. 262, pp. 129921-129921
Closed Access | Times Cited: 5
The role of molecular imaging in detecting fibrosis in Crohn’s disease
Ali S. Alyami, Yahia Madkhali, Naif A. Majrashi, et al.
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access | Times Cited: 5
Ali S. Alyami, Yahia Madkhali, Naif A. Majrashi, et al.
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access | Times Cited: 5
Estrogen Receptor β Activation Mitigates Colitis-associated Intestinal Fibrosis via Inhibition of TGF-β/Smad and TLR4/MyD88/NF-κB Signaling Pathways
Fangmei Ling, Yidong Chen, Junrong Li, et al.
Inflammatory Bowel Diseases (2024) Vol. 31, Iss. 1, pp. 11-27
Closed Access | Times Cited: 5
Fangmei Ling, Yidong Chen, Junrong Li, et al.
Inflammatory Bowel Diseases (2024) Vol. 31, Iss. 1, pp. 11-27
Closed Access | Times Cited: 5
How to Evaluate Fibrosis in IBD?
Helena Tavares de Sousa, Fernando Magro
Diagnostics (2023) Vol. 13, Iss. 13, pp. 2188-2188
Open Access | Times Cited: 11
Helena Tavares de Sousa, Fernando Magro
Diagnostics (2023) Vol. 13, Iss. 13, pp. 2188-2188
Open Access | Times Cited: 11
Stromal Cell Regulation of Intestinal Inflammatory Fibrosis
Wenjing Yang, Tianming Yu, Yingzi Cong
Cellular and Molecular Gastroenterology and Hepatology (2024) Vol. 17, Iss. 5, pp. 703-711
Open Access | Times Cited: 4
Wenjing Yang, Tianming Yu, Yingzi Cong
Cellular and Molecular Gastroenterology and Hepatology (2024) Vol. 17, Iss. 5, pp. 703-711
Open Access | Times Cited: 4
Characterization of patient-derived intestinal organoids for modelling fibrosis in Inflammatory Bowel Disease
Ilaria Laudadio, Claudia Carissimi, Noemi Scafa, et al.
Inflammation Research (2024) Vol. 73, Iss. 8, pp. 1359-1370
Open Access | Times Cited: 4
Ilaria Laudadio, Claudia Carissimi, Noemi Scafa, et al.
Inflammation Research (2024) Vol. 73, Iss. 8, pp. 1359-1370
Open Access | Times Cited: 4
Deciphering SPP1-related macrophage signaling in the pathogenesis of intervertebral disc degeneration
Xiaojun Yu, Peng Zou, Leo Li, et al.
Cell Biology and Toxicology (2025) Vol. 41, Iss. 1
Open Access
Xiaojun Yu, Peng Zou, Leo Li, et al.
Cell Biology and Toxicology (2025) Vol. 41, Iss. 1
Open Access
Prominence of Microbiota to Predict Fibrous Stenosis in Crohn’s Disease
Xue Yang, Yan Pan, Cai-Ping Gao, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 1413-1423
Open Access
Xue Yang, Yan Pan, Cai-Ping Gao, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 1413-1423
Open Access